0001635568-25-000002.txt : 20251230 0001635568-25-000002.hdr.sgml : 20251230 20251230132857 ACCESSION NUMBER: 0001635568-25-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20251230 DATE AS OF CHANGE: 20251230 EFFECTIVENESS DATE: 20251230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pearl Biotech & Life Sciences Fund, L.P. CENTRAL INDEX KEY: 0001635568 ORGANIZATION NAME: EIN: 472663766 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-250050 FILM NUMBER: 251613154 BUSINESS ADDRESS: STREET 1: 887 CENTRILLION DR. CITY: MCLEAN STATE: VA ZIP: 22102 BUSINESS PHONE: 571-329-3610 MAIL ADDRESS: STREET 1: 887 CENTRILLION DR. CITY: MCLEAN STATE: VA ZIP: 22102 D/A 1 primary_doc.xml X0708 D/A LIVE 0001635568 Pearl Biotech & Life Sciences Fund, L.P. 887 CENTRILLION DR. MCLEAN VA VIRGINIA 22102 571-329-3610 DELAWARE None None Limited Partnership true N/A Bravance Healthcare Investors, LLC 887 Centrillion Dr. McLean VA VIRGINIA 22102 Executive Officer General Partner of the Issuer. Lynt Johnson 887 Centrillion Dr. McLean VA VIRGINIA 22102 Executive Officer Managing Member of Bravance Healthcare Investors, LLC. Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0001635568-24-000001 2018-03-12 true true false 0 Indefinite 4611000 Indefinite false 20 0 true 0 true 0 true Bravance Healthcare Investors, LLC and certain persons listed in item 3 may receive a management fee based on the value of the issuer's assets and/or a performance fee based on the issuer's profits. false Pearl Biotech & Life Sciences Fund, L.P. Lynt Johnson Lynt Johnson Managing Member of Bravance Healthcare Investors, LLC 2025-12-30